We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$721M
AUM Growth
+$3.8M
Cap. Flow
-$22.4M
Cap. Flow %
-3.1%
Top 10 Hldgs %
29.13%
Holding
154
New
13
Increased
38
Reduced
45
Closed
15

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$6.22M
2
COR icon
Cencora
COR
+$5.63M
3
ILMN icon
Illumina
ILMN
+$5.46M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.98M
5
PRGO icon
Perrigo
PRGO
+$4.77M

Top Sells

Rank Stock Value
1
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$18.9M
2
BAX icon
Baxter International
BAX
+$9.56M
3
CNC icon
Centene
CNC
+$8.47M
4
LCI
Lannett Company, Inc.
LCI
+$6.61M
5
MOH icon
Molina Healthcare
MOH
+$6.39M

Sector Composition

Rank Sector Weight
1 Healthcare 90.06%
2 Financials 0.8%
3 Industrials 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
26
McKesson
MCK
$101B
$9.22M 1.28%
41,000
– –
BMRN icon
27
BioMarin Pharmaceuticals
BMRN
$12.4B
$8.89M 1.23%
65,000
-36,000
-36% -$4.46M
LGND icon
28
Ligand Pharmaceuticals
LGND
$6.36B
$7.69M 1.07%
122,133
-27,202
-18% -$1.48M
PRGO icon
29
Perrigo
PRGO
$1.78B
$7.39M 1.03%
40,000
+25,000
+167% +$4.77M
CI icon
30
Cigna
CI
$74.6B
$7.29M 1.01%
45,000
– –
CHRS icon
31
Coherus Oncology
CHRS
$196M
$7.22M 1%
250,000
+170,000
+213% +$4.3M
RDY icon
32
Dr. Reddy's Laboratories
RDY
$10.2B
$7.19M 1%
650,000
+150,000
+30% +$1.66M
BSX icon
33
Boston Scientific
BSX
$71.5B
$7.08M 0.98%
400,000
-4,000
-1% -$71.5K
THC icon
34
Tenet Healthcare
THC
$21.1B
$7.06M 0.98%
121,950
+71,950
+144% +$3.68M
ALKS icon
35
Alkermes
ALKS
$8.25B
$7.04M 0.98%
109,500
+23,000
+27% +$1.41M
IONS icon
36
Ionis Pharmaceuticals
IONS
$9.4B
$7.02M 0.97%
122,000
-25,000
-17% -$1.59M
MDVN
37
DELISTED
MEDIVATION, INC.
MDVN
$7M 0.97%
122,600
+14,000
+13% +$863K
SHPG
38
DELISTED
Shire pic
SHPG
$6.71M 0.93%
27,800
+16,800
+153% +$4.17M
ISRG icon
39
Intuitive Surgical
ISRG
$134B
$6.57M 0.91%
121,950
– –
ALNY icon
40
Alnylam Pharmaceuticals
ALNY
$29.3B
$6.47M 0.9%
54,000
-10,000
-16% -$1.2M
RCPT
41
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$6.46M 0.9%
34,000
-14,000
-29% -$2.31M
COR icon
42
Cencora
COR
$61.2B
$6.38M 0.89%
60,000
+50,000
+500% +$5.63M
INCY icon
43
Incyte
INCY
$24.4B
$5.94M 0.82%
57,000
-31,352
-35% -$3.25M
MNK
44
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$5.89M 0.82%
50,000
-20,000
-29% -$2.47M
NVAX icon
45
Novavax
NVAX
$1.31B
$5.79M 0.8%
26,000
– –
AET
46
DELISTED
Aetna Inc
AET
$5.74M 0.8%
45,000
-14,000
-24% -$1.6M
AKRX
47
DELISTED
Akorn Inc
AKRX
$5.59M 0.78%
128,050
-16,950
-12% -$784K
CVS icon
48
CVS Health
CVS
$122B
$5.24M 0.73%
50,000
+20,000
+67% +$2.04M
HZNP
49
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.21M 0.72%
+150,000
New +$4.58M
BCR
50
DELISTED
CR Bard Inc.
BCR
$5.12M 0.71%
30,000
– –
1
2
3 4 5

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.57% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q2 2015 Portfolio in Review

As of Q2 2015, Bellevue Asset Management (Switzerland) held 154 positions worth $721M, up 0.53% from $717M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bellevue Asset Management (Switzerland) withdrew a net $22.4M in Q2 2015, closing 15 positions and reducing 45 holdings. Its most notable exit was CATAMARAN CORP COM STK (CDA), an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 85% a quarter earlier, followed by Financials and Industrials.

Against the trend, Bellevue Asset Management (Switzerland) opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $5.21M.

  • Bellevue Asset Management (Switzerland)'s largest Q2 2015 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 150,000 shares worth $5.21M.
  • Bellevue Asset Management (Switzerland) added most to Endo International plc in Q2 2015, an estimated $6.22M increase.
  • Bellevue Asset Management (Switzerland)'s biggest Q2 2015 reduction was Centene, cutting an estimated $8.47M.
  • Bellevue Asset Management (Switzerland) fully exited CATAMARAN CORP COM STK (CDA) in Q2 2015, selling an estimated $18.9M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 29% of its $721M portfolio in Q2 2015.
  • Bellevue Asset Management (Switzerland) opened 13 new positions and closed 15 in Q2 2015.
  • Bellevue Asset Management (Switzerland)'s portfolio value rose 0.53% quarter-over-quarter to $721M.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q2 2015, filed 12 Aug 2015.